Patrick Rivelli has been a medical device entrepreneur and investor for over 25 years. He is currently President and CEO of Sonogenix, Inc., a clinical stage medical device company; as well as Co-Director and Life Sciences Track Lead at MIT Angels, an angel investor group. He was previously founder and CEO of Smart Therapeutics (acquired by Boston Scientific) & Bioabsorbable Therapeutics (acquired by Multi Cell Corporation). Patrick holds a BA in Economics from Harvard University and a MS in Management from the MIT Sloan School. He also holds 9 issued patents.